Rafferty Asset Management’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $3.28M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $2.74M | Sell |
|
|||||
|
2022
Q4 | $3.72M | Buy |
|
|||||
|
2022
Q3 | $2.58M | Buy |
|
|||||
|
2022
Q2 | $1.67M | Sell |
|
|||||
|
2022
Q1 | $3.52M | Buy |
|
|||||
|
2021
Q4 | $2.9M | Buy |
|
|||||
|
2021
Q3 | $1.99M | Sell |
|
|||||
|
2021
Q2 | $2.49M | Sell |
|
|||||
|
2021
Q1 | $3M | Buy |
|
|||||
|
2020
Q4 | $736K | Sell |
|
|||||
|
2020
Q3 | $1.85M | Buy |
|
|||||
|
2020
Q2 | $1.06M | Buy |
|
|||||
|
2020
Q1 | $225K | Sell |
|
|||||
|
2019
Q4 | $2.46M | Sell |
|
|||||
|
2019
Q3 | $3.14M | Buy |
|
|||||
|
2019
Q2 | $2.3M | Buy |
|
|||||
|
2019
Q1 | $1.25M | Buy |
|